These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23248065)

  • 1. Should left ventricular assist device be standard of care for patients with refractory heart failure who are not transplantation candidates?: left ventricular assist devices should not be standard of care for transplantation-ineligible patients.
    Owens AT; Jessup M
    Circulation; 2012 Dec; 126(25):3088-94. PubMed ID: 23248065
    [No Abstract]   [Full Text] [Related]  

  • 2. Should left ventricular assist device should be standard of care for patients with refractory heart failure who are not transplantation candidates?: left ventricular assist devices should be considered standard of care for patients with refractory heart failure who are not transplantation candidates.
    Mehra MR; Domanski MJ
    Circulation; 2012 Dec; 126(25):3081-7. PubMed ID: 23248064
    [No Abstract]   [Full Text] [Related]  

  • 3. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of a left ventricular assist device for end-stage heart failure.
    Rose EA; Gelijns AC; Moskowitz AJ; Heitjan DF; Stevenson LW; Dembitsky W; Long JW; Ascheim DD; Tierney AR; Levitan RG; Watson JT; Meier P; Ronan NS; Shapiro PA; Lazar RM; Miller LW; Gupta L; Frazier OH; Desvigne-Nickens P; Oz MC; Poirier VL;
    N Engl J Med; 2001 Nov; 345(20):1435-43. PubMed ID: 11794191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a pulsatile right ventricular assist device and continuous arteriovenous hemodialysis in a 57-year-old man with a pulsatile left ventricular assist device.
    Chen JM; Levin HR; Catanese KA; Sistino JJ; Landry DW; Rose EA; Oz MC
    J Heart Lung Transplant; 1995; 14(1 Pt 1):186-91. PubMed ID: 7727468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac extracorporeal life support: state of the art in 2007.
    Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
    Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.
    Grady KL; Meyer PM; Dressler D; Mattea A; Chillcott S; Loo A; White-Williams C; Todd B; Ormaza S; Kaan A; Costanzo MR; Piccione W
    Ann Thorac Surg; 2004 Apr; 77(4):1321-7. PubMed ID: 15063260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular assist device application with the intermediate use of a membrane oxygenator as a bridge to pediatric heart transplantation.
    Garcia-Guereta L; Cabo J; de la Oliva P; Villar MA; Bronte LD; Goldman L; Hübler M
    J Heart Lung Transplant; 2009 Jul; 28(7):740-2. PubMed ID: 19560705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
    Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous-flow left ventricular assist device and the right ventricle.
    Puhlman M
    AACN Adv Crit Care; 2012; 23(1):86-90. PubMed ID: 22290094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients supported for over 4 years with left ventricular assist devices.
    Potapov EV; Jurmann MJ; Drews T; Pasic M; Loebe M; Weng Y; Hetzer R
    Eur J Heart Fail; 2006 Nov; 8(7):756-9. PubMed ID: 16556510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upstream palliative care for the patient with a left ventricular assist device as destination therapy.
    Byram EK
    Dimens Crit Care Nurs; 2012; 31(1):18-24. PubMed ID: 22156807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement.
    Soderlund KA; Chivukula RR; Russell SD; Conte JV; Mudd JO; Halushka MK
    Cardiovasc Pathol; 2009; 18(4):217-22. PubMed ID: 18706833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged use of right ventricular assist device for refractory graft failure following orthotopic heart transplantation.
    Bajona P; Salizzoni S; Brann SH; Coyne J; Bermudez C; Kormos R; Toyoda Y
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):e53-4. PubMed ID: 19660327
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of the Flowmaker (Jarvik 2000) left ventricular assist device for destination therapy and bridging to transplantation.
    Frazier OH; Shah NA; Myers TJ; Robertson KD; Gregoric ID; Delgado R
    Cardiology; 2004; 101(1-3):111-6. PubMed ID: 14988632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HeartMate left ventricular assist device on cardiac autonomic nervous activity.
    Kim SY; Montoya A; Zbilut JP; Mawulawde K; Sullivan HJ; Lonchyna VA; Terrell MR; Pifarré R
    Ann Thorac Surg; 1996 Feb; 61(2):591-3. PubMed ID: 8572772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.